TP53 mutations in serous tubal intraepithelial carcinoma, the putative precursor lesion of ovarian high-grade serous carcinoma

被引：0
|
作者：
Kuhn, Elisabetta [1 ]
Kurman, Robert J. [1 ]
Soslow, Robert A. [2 ]
Han, Guangming [2 ]
Wang, Tian-Li [1 ]
Shih, Le-Ming [1 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
221
引用
收藏
页数：1
相关论文
共 50 条
  • [21] TP53 mutations as a biomarker for high-grade serous ovarian cancer: are we there yet?
    Oien, Derek B.
    Chien, Jeremy
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S264 - S268
  • [22] Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
    Musaffe Tuna
    Zhenlin Ju
    Kosuke Yoshihara
    Christopher I. Amos
    Janos L. Tanyi
    Gordon B. Mills
    British Journal of Cancer, 2020, 122 : 405 - 412
  • [23] High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review
    Novikov, Filipp Vladimirovich
    Anufriev, Aleksandr Grigorevich
    Efremov, Gennadii Dmitrievich
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (06) : 626 - 630
  • [24] High-grade serous ovarian carcinoma detected with TP53 mutation panel and SiMSen-Seq
    Widjaja, Amanda Olsson
    Micallef, Peter
    Ulfenborg, Benjamin
    Lycke, Maria
    Gyllensten, Ulf
    Carlsson, Therese
    Osterlund, Tobias
    Stahlberg, Anders
    Linder, Anna
    Sundfeldt, Karin
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Frequency of serous tubal intraepithelial carcinoma (STIC) in patients with high grade serous ovarian cancer
    Byun, Jung Mi
    Cho, Hwa Jin
    Lee, Dae Sim
    Yoon, Hye Kyoung
    Kim, Young Nam
    Im, Do Hwa
    Kim, Da Hyun
    Lee, Kyung Bok
    Sung, Moon Su
    Jeong, Dae Hoon
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (01): : 107 - 111
  • [26] Circulating TP53 mutations as a biomarker of high-grade serous cancer
    Christie, Elizabeth
    Hunter, Tane
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2015, 21
  • [27] Serous tubal intraepithelial carcinoma and tubal-peritoneal tranzition zone - new aspects in high-grade serous carcinoma pathogenesis
    Asaturova, Alexandra
    Adamyan, Leila
    Ezhova, Larisa
    Fayzullina, Nafisa
    Sannikova, Maya
    Chabas, Grigory
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 58 - 59
  • [28] Proliferative Activity in Serous Tubal Intraepithelial Carcinoma Compare to Adjacent Normal Tubal Epithelium and Concurrent High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Sehdev, A. E. Smith
    Shih, I-M
    LABORATORY INVESTIGATION, 2011, 91 : 254A - 254A
  • [29] Proliferative Activity in Serous Tubal Intraepithelial Carcinoma Compare to Adjacent Normal Tubal Epithelium and Concurrent High-Grade Serous Carcinoma
    Kuhn, E.
    Kurman, R. J.
    Sehdev, A. E. Smith
    Shih, I-M
    MODERN PATHOLOGY, 2011, 24 : 254A - 254A
  • [30] Studying the effect of germline polymorphisms on somatic hotspot mutations in TP53 for the treatment of high-grade serous ovarian carcinoma.
    de Souza, Cristabelle Madona N.
    Chien, Jeremy
    Madden, Jill
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 103 - 104
12345